ProsTIC PCF Global Knowledge Exchange Webinar - Alphas and New Targets
ProsTIC TV ProsTIC TV
917 subscribers
579 views
0

 Published On Jul 21, 2023

๐ŸŒ ๐—˜๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ฒ ๐—ก๐—ฒ๐˜„ ๐—™๐—ฟ๐—ผ๐—ป๐˜๐—ถ๐—ฒ๐—ฟ๐˜€ ๐—ผ๐—ณ ๐—ฃ๐—ฟ๐—ผ๐˜€๐˜๐—ฎ๐˜๐—ฒ ๐—–๐—ฎ๐—ป๐—ฐ๐—ฒ๐—ฟ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ๐˜€ ๐ŸŒ

๐Ÿ”ฌ Our hosts: Prof Declan Murphy, Prof Michael Hofman, Dr Howard Soule & Dr Andrea Miyahira are eager to engage with you

๐ŸŽ™๏ธ Very Special Guests:
Prof. Lisa Bodei, Memorial Sloan Kettering Cancer Center
Prof. Michael Morris, Memorial Sloan Kettering Cancer Center
A/Prof. David Pattison, Royal Brisbane & Women's Hospital
Dr. Marwa Rahimi, Peter MacCallum Cancer Centre
Dr. Megan Crumbaker, St Vincent's Hospital Sydney
+ interactive Q&A

๐ŸŽฏ Key Discussion Points:
Alpha Therapy: Exploring Lead-212, Actinium-223 & beyond
New Theranostic Targets: What's the post-PSMA landscape looking like?
The complexities and potential of Treating Neuroendocrine Prostate Cancer

Live from the GU Cast studio in Melbourne, Australia..

show more

Share/Embed